Rady Children's Specialists of San Diego
Rady Children's Specialists
University of California Los Angeles
Cedars-Sinai Medical Center
UC San Diego
Pediatric Infectious Diseases, Pediatrics
Dr. Adriana Tremoulet is the associate director of the Kawasaki Disease Research Center at UC San Diego. In this role, she cares for nearly 1,500 children with Kawasaki disease in San Diego County and an additional 90 children a year hospitalized at Rady Children's Hospital-San Diego .
Dr. Tremoulet graduated from Harvard University with a major in biochemistry and attended medical school at the University of California, Los Angeles. During medical school, she spent a year as a fellow in the National Institutes of Health Clinical Research Training Program. She then completed her residency at Cedars-Sinai Medical Center and her pediatric infectious disease fellowship at UC San Diego.
In 2013, Dr. Tremoulet was appointed as the associate director of clinical research at Rady Children's. She is also the site principal investigator for the National Institute of Child Health and Human Development-funded Pediatric Trials Network and Research Program in Developmental Pharmacology at UC San Diego. Dr. Tremoulet has led Phase I through III clinical trials, including a Food and Drug Administration Orphan Products grant-funded Phase III clinical trial on the use of infliximab as adjunctive primary therapy in Kawasaki disease.
Development of Tolerance to Chronic Intermittent Furosemide Therapy in Pediatric Patients.
Kim GJ, Capparelli E, Romanowski G, Proudfoot JA, Tremoulet AH
Pediatric tolerogenic DCs expressing CD4 and immunoglobulin-like transcript receptor (ILT)-4 secrete IL-10 in response to Fc and adenosine.
Franco A, Kumar J, Lin G, Behnamfar N, Hsieh LE, Shimizu C, Tremoulet AH, Burns JC, Linden J
Adjunctive therapies in Kawasaki disease.
Fever without a source: evolution of a diagnosis from Kawasaki disease to acute myelogenous leukaemia.
Lee B, Kofman CD, Tremoulet AH, Kuo DJ
High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease.
Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, Tremoulet AH
Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility.
Kim J, Shimizu C, Kingsmore SF, Veeraraghavan N, Levy E, Ribeiro Dos Santos AM, Yang H, Flatley J, Hoang LT, Hibberd ML, Tremoulet AH, Harismendy O, Ohno-Machado L, Burns JC
Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
Wang Y, Li Z, Hu G, Hao S, Deng X, Huang M, Ren M, Jiang X, Kanegaye JT, Ha KS, Lee J, Li X, Jiang X, Yu Y, Tremoulet AH, Burns JC, Whitin JC, Shin AY, Sylvester KG, McElhinney DB, Cohen HJ, Ling XB, Pediatric Emergency Medicine Kawasaki Disease Research Group.
miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.
He M, Chen Z, Martin M, Zhang J, Sangwung P, Woo B, Tremoulet AH, Shimizu C, Jain MK, Burns JC, Shyy JY
Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients.
Lee AM, Burns JC, Tremoulet AH
Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities.
Shimizu C, Eleftherohorinou H, Wright VJ, Kim J, Alphonse MP, Perry JC, Cimaz R, Burgner D, Dahdah N, Hoang LT, Khor CC, Salgado A, Tremoulet AH, Davila S, Kuijpers TW, Hibberd ML, Johnson TA, Takahashi A, Tsunoda T, Kubo M, Tanaka T, Onouchi Y, Yeung RS, Coin LJ, Levin M, Burns JC, International Kawasaki Disease Genetics Consortium.
Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.
Burns JC, KonÃ©-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M
Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.
Hornik CP, Benjamin DK Jr, Smith PB, Pencina MJ, Tremoulet AH, Capparelli EV, Ericson JE, Clark RH, Cohen-Wolkowiez M, Best Pharmaceuticals for Children Actâ€”Pediatric Trials Network.
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW
Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
Connelly MA, Shimizu C, Winegar DA, Shalaurova I, Pourfarzib R, Otvos JD, Kanegaye JT, Tremoulet AH, Burns JC
Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children.
Herberg JA, Kaforou M, Wright VJ, Shailes H, Eleftherohorinou H, Hoggart CJ, Cebey-LÃ³pez M, Carter MJ, Janes VA, Gormley S, Shimizu C, Tremoulet AH, Barendregt AM, Salas A, Kanegaye J, Pollard AJ, Faust SN, Patel S, Kuijpers T, MartinÃ³n-Torres F, Burns JC, Coin LJ, Levin M, IRIS Consortium.
A Classification Tool for Differentiation of Kawasaki Disease from OtherÂ Febrile Illnesses.
Hao S, Jin B, Tan Z, Li Z, Ji J, Hu G, Wang Y, Deng X, Kanegaye JT, Tremoulet AH, Burns JC, Cohen HJ, Ling XB, Pediatric Emergency Medicine KawasakiÂ DiseaseÂ Research Group.
Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
Tremoulet AH, Jain S, Kim S, Newburger J, Arditi M, Franco A, Best B, Burns JC
Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype.
Haddock ES, Calame A, Shimizu C, Tremoulet AH, Burns JC, Tom WL
Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses.
Li Z, Tan Z, Hao S, Jin B, Deng X, Hu G, Liu X, Zhang J, Jin H, Huang M, Kanegaye JT, Tremoulet AH, Burns JC, Wu J, Cohen HJ, Ling XB, Emergency Medicine Kawasaki Disease Research Group.
Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes.
Doan S, Maehara CK, Chaparro JD, Lu S, Liu R, Graham A, Berry E, Hsu CN, Kanegaye JT, Lloyd DD, Ohno-Machado L, Burns JC, Tremoulet AH, Pediatric Emergency Medicine Kawasaki Disease Research Group.
Pulmonary Artery Dilation and Right Ventricular Function in Acute Kawasaki Disease.
Numano F, Shimizu C, Tremoulet AH, Dyar D, Burns JC, Printz BF
Kawasaki Disease in Latin American Children: Past, Current, and Future Challenges.
Ulloa-Gutierrez R, Salgado AP, Tremoulet AH
Axillary, Oral and Rectal Routes of Temperature Measurement During Treatment of Acute Kawasaki Disease.
Kanegaye JT, Jones JM, Burns JC, Jain S, Sun X, Jimenez-Fernandez S, Berry E, Pancheri JM, Jaggi P, Ramilo O, Tremoulet AH
Patterns of Fever in Children After Primary Treatment for Kawasaki Disease.
Jaggi P, Wang W, Dvorchik I, Printz B, Berry E, Kovalchin JP, Texter K, Ramilo O, Burns JC, Tremoulet AH
Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms.
Numano F, Shimizu C, Jimenez-Fernandez S, Vejar M, Oharaseki T, Takahashi K, Salgado A, Tremoulet AH, Gordon JB, Burns JC, Daniels LB
See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.
PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.
Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at firstname.lastname@example.org.